Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T, Galaris A, Chrysikos S, Papaioannou O, Vamvakaris I, Barbayianni I, Kanellopoulou P, Grammenoudi S, Anagnostopoulos N, Stratakos G, Katsaras M, Sampsonas F, Dimakou K, Manali ED, Papiris S, Tourki B, Juan-Guardela BM, Bakakos P, Bouros D, Herazo-Maya JD, Aidinis V, Tzouvelekis A. Karampitsakos T, et al. Among authors: chrysikos s. Respir Res. 2023 Nov 14;24(1):279. doi: 10.1186/s12931-023-02551-x. Respir Res. 2023. PMID: 37964265 Free PMC article.
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.
Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, Sampsonas F, Katsaras M, Vasarmidi E, Papakosta D, Domvri K, Fouka E, Organtzis I, Daniil Z, Dimeas I, Kirgou P, Gourgoulianis KI, Papanikolaou IC, Markopoulou K, Kounti G, Tsapakidou E, Papadopoulou E, Tatsis K, Gogali A, Kostikas K, Tzilas V, Chrysikos S, Papiris S, Bouros D, Kreuter M, Tzouvelekis A. Karampitsakos T, et al. Among authors: chrysikos s. Respir Res. 2021 May 5;22(1):140. doi: 10.1186/s12931-021-01725-9. Respir Res. 2021. PMID: 33952261 Free PMC article.
Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.
Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D. Tzouvelekis A, et al. Among authors: chrysikos s. Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31. Pulm Pharmacol Ther. 2018. PMID: 29366978
Pulmonary hypertension in patients with interstitial lung disease.
Karampitsakos T, Tzouvelekis A, Chrysikos S, Bouros D, Tsangaris I, Fares WH. Karampitsakos T, et al. Among authors: chrysikos s. Pulm Pharmacol Ther. 2018 Jun;50:38-46. doi: 10.1016/j.pupt.2018.03.002. Epub 2018 Mar 29. Pulm Pharmacol Ther. 2018. PMID: 29605286 Review.
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
Tzouvelekis A, Karampitsakos T, Gomatou G, Bouros E, Tzilas V, Manali E, Tomos I, Trachalaki A, Kolilekas L, Korbila I, Tomos P, Chrysikos S, Gaga M, Daniil Z, Bardaka F, Papanikolaou IC, Euthymiou C, Papakosta D, Steiropoulos P, Ntolios P, Tringidou R, Papiris S, Antoniou K, Bouros D. Tzouvelekis A, et al. Among authors: chrysikos s. Pulm Pharmacol Ther. 2020 Feb;60:101880. doi: 10.1016/j.pupt.2019.101880. Epub 2019 Dec 23. Pulm Pharmacol Ther. 2020. PMID: 31874284
Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.
Tzouvelekis A, Akinosoglou K, Karampitsakos T, Panou V, Tomos I, Tsoukalas G, Stratiki M, Dimakou K, Chrysikos S, Papaioannou O, Hillas G, Bakakos P, Stratakos G, Anagnostopoulos A, Koromilias A, Boutou A, Kioumis I, Chloros D, Kontakiotis T, Papakosta D, Papiris S, Manali E, Antonogiannaki EM, Koulouris N, Bouros D, Loukides S, Gogos C. Tzouvelekis A, et al. Among authors: chrysikos s. Adv Respir Med. 2021;89(4):378-385. doi: 10.5603/ARM.a2021.0087. Adv Respir Med. 2021. PMID: 34494241 Free article.
Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.
Karampitsakos T, Kalogeropoulou C, Tzilas V, Papaioannou O, Kazantzi A, Koukaki E, Katsaras M, Bouros E, Tsiri P, Tsirikos G, Zarkadi E, Ntoulias N, Sotiropoulou V, Efthymiou P, Chrysikos S, Malakounidou E, Sampsonas F, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Among authors: chrysikos s. Respiration. 2022;101(3):262-271. doi: 10.1159/000519215. Epub 2021 Sep 30. Respiration. 2022. PMID: 34592744
Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.
Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D. Tzouvelekis A, et al. Among authors: chrysikos s. Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29238708 Free PMC article.
Metabolic Disorders in Chronic Lung Diseases.
Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, Bouros D, Aidinis V, Tzouvelekis A. Papaioannou O, et al. Among authors: chrysikos s. Front Med (Lausanne). 2018 Jan 18;4:246. doi: 10.3389/fmed.2017.00246. eCollection 2017. Front Med (Lausanne). 2018. PMID: 29404325 Free PMC article. Review.
26 results